Loading insider details...
Beta
Latest Form 4 (Jul 29, 2026): Grant/Award of 9,450 PCSA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 29, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/Award | 9,450 | n/a |
| Jul 1, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 2,436 | $4.7K |
| Jun 16, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 2,118 | $4.7K |
| Jun 1, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 1,829 | $4.7K |
| May 19, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 1,583 | $4.7K |
| May 1, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 1,748 | $4.7K |
| Apr 17, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 1,583 | $4.7K |
| Apr 1, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 1,854 | $4.7K |
| Feb 4, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Exercise/Conversion | 193 | n/a |
| Oct 3, 2025 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/Award | 50,000 | n/a |